{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:40:24Z","timestamp":1777531224088,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Foundation of China (NSFC)","award":["JC;30825043"],"award-info":[{"award-number":["JC;30825043"]}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"crossref","award":["JC; 21172202"],"award-info":[{"award-number":["JC; 21172202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.antiviral.2012.10.003","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T12:44:48Z","timestamp":1350996288000},"page":"333-339","source":"Crossref","is-referenced-by-count":21,"title":["Anti-hepatitis B virus activities of \u03b1-DDB\u2013FNC, a novel nucleoside\u2013biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice"],"prefix":"10.1016","volume":"96","author":[{"given":"Qinghua","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingduan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.10.003_b0005","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3748\/wjg.v10.i18.2666","article-title":"Establishment and assessment of two methods for quantitative detection of serum duck hepatitis B virus DNA","volume":"10","author":"Chen","year":"2004","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"10.1016\/j.antiviral.2012.10.003_b0010","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1248\/bpb.33.1728","article-title":"Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells","volume":"33","author":"Cui","year":"2010","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2012.10.003_b0015","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1136\/gutjnl-2012-302056","article-title":"New insight in the pathobiology of hepatitis B virus infection","volume":"61","author":"Dandri","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2012.10.003_b0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/AAC.46.2.425-433.2002","article-title":"Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro","volume":"46","author":"Delmas","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.antiviral.2012.10.003_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-1759(90)90187-Z","article-title":"MTT colorimetric assay for testing macrophage cytotoxic activity in vitro","volume":"131","author":"Ferrari","year":"1990","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.antiviral.2012.10.003_b0035","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1478-3231.2005.01140.x","article-title":"Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice","volume":"25","author":"Gao","year":"2005","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.antiviral.2012.10.003_b0030","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3748\/wjg.14.1263","article-title":"Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells","volume":"14","author":"Gao","year":"2008","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"10.1016\/j.antiviral.2012.10.003_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2007.01.002","article-title":"Anti-hepatitis B virus activity of wogonin in vitro and in vivo","volume":"74","author":"Guo","year":"2007","journal-title":"Antiviral Research"},{"key":"10.1016\/j.antiviral.2012.10.003_b0045","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.3748\/wjg.v17.i21.2663","article-title":"Protective effects of 2,4-dihydroxybenzophenone against acetaminophen-induced hepatotoxicity in mice","volume":"17","author":"He","year":"2011","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"10.1016\/j.antiviral.2012.10.003_b0050","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1248\/bpb.32.1215","article-title":"Hepatoprotective effect of syringic acid and vanillic acid on concanavalin a-induced liver injury","volume":"32","author":"Itoh","year":"2009","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.antiviral.2012.10.003_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10637-006-9001-z","article-title":"The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis","volume":"25","author":"Jin","year":"2007","journal-title":"Investigational New Drugs"},{"key":"10.1016\/j.antiviral.2012.10.003_b0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2009.06.024","article-title":"Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis","volume":"386","author":"Kajiya","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.antiviral.2012.10.003_b0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ptr.832","article-title":"Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus","volume":"15","author":"Kim","year":"2001","journal-title":"Phytotherapy Research: PTR"},{"key":"10.1016\/j.antiviral.2012.10.003_b0070","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1074\/jbc.M708929200","article-title":"2\u2032-Deoxy-4\u2032-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2\u2032-alpha-hydroxyl groups","volume":"283","author":"Klumpp","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.antiviral.2012.10.003_b0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1756283X08093944","article-title":"Current status of antiviral therapy for hepatitis B","volume":"1","author":"Lau","year":"2008","journal-title":"Therapeutic Advances in Gastroenterology"},{"key":"10.1016\/j.antiviral.2012.10.003_b0080","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/AAC.46.8.2525-2532.2002","article-title":"Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro","volume":"46","author":"Levine","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.antiviral.2012.10.003_b0100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10529-006-9007-9","article-title":"Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum","volume":"28","author":"Li","year":"2006","journal-title":"Biotechnology Letters"},{"key":"10.1016\/j.antiviral.2012.10.003_b0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3748\/wjg.v11.i3.426","article-title":"Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo","volume":"11","author":"Li","year":"2005","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"10.1016\/j.antiviral.2012.10.003_b0095","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1631\/jzus.2005.B0664","article-title":"Character of HBV (hepatitis B virus) polymerase gene rtM204V\/I and rtL180M mutation in patients with lamivudine resistance","volume":"6","author":"Li","year":"2005","journal-title":"Journal of Zhejiang University Science B"},{"key":"10.1016\/j.antiviral.2012.10.003_b0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.antiviral.2008.03.001","article-title":"In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L","volume":"79","author":"Li","year":"2008","journal-title":"Antiviral Research"},{"key":"10.1016\/j.antiviral.2012.10.003_b0105","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/147323000903700515","article-title":"Inhibition of the replication of hepatitis B virus in vitro by oxymatrine","volume":"37","author":"Lin","year":"2009","journal-title":"The Journal of International Medical Research"},{"key":"10.1016\/j.antiviral.2012.10.003_b0110","doi-asserted-by":"crossref","unstructured":"Liu, G.T., 2009. Bicyclol: a novel drug for treating chronic viral hepatitis B and C. Medicinal Chemistry (Shariqah, United Arab Emirates) 5, 29\u201343.","DOI":"10.2174\/157340609787049316"},{"key":"10.1016\/j.antiviral.2012.10.003_b0115","first-page":"1193","article-title":"[The protective effect of XD in ConA-induced liver injury]","volume":"26","author":"Liu","year":"2010","journal-title":"Xi bao yu fen zi mian yi xue za zhi = Chinese Journal of Cellular and Molecular Immunology"},{"key":"10.1016\/j.antiviral.2012.10.003_b0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/1566524033479591","article-title":"Mechanisms of viral hepatitis induced liver injury","volume":"3","author":"Nakamoto","year":"2003","journal-title":"Current Molecular Medicine"},{"key":"10.1016\/j.antiviral.2012.10.003_b0125","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1572-0241.2002.05819.x","article-title":"Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance","volume":"97","author":"Papatheodoridis","year":"2002","journal-title":"The American Journal of Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.antiviral.2012.10.003_b0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2005-915647","article-title":"Current treatment of chronic hepatitis B: benefits and limitations","volume":"25","author":"Perrillo","year":"2005","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.antiviral.2012.10.003_b0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00210-011-0685-z","article-title":"Protective effect of andrographolide against concanavalin A-induced liver injury","volume":"385","author":"Shi","year":"2012","journal-title":"Naunyn\u2013Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.antiviral.2012.10.003_b0150","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1021\/jm100803c","volume":"53","author":"Srivastav","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.antiviral.2012.10.003_b0135","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1016\/j.bmc.2008.12.007","article-title":"Anti-HBV and cytotoxic activities of pyranocoumarin derivatives","volume":"17","author":"Su","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.antiviral.2012.10.003_b0140","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2008.03816.x","article-title":"Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma","volume":"28","author":"Sung","year":"2008","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.antiviral.2012.10.003_b0155","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bcp.2011.01.001","article-title":"FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells","volume":"81","author":"Wang","year":"2011","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.antiviral.2012.10.003_b0160","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1745-7254.2007.00590.x","article-title":"Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment","volume":"28","author":"Xie","year":"2007","journal-title":"Acta Pharmacologica Sinica"},{"issue":"Suppl 1","key":"10.1016\/j.antiviral.2012.10.003_b0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2010.06545.x","article-title":"Treatment of chronic hepatitis B: evolution over two decades","volume":"26","author":"Yuen","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.antiviral.2012.10.003_b0170","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3851\/IMP2094","article-title":"Antiviral activity of FNC, 2\u2032-deoxy-2\u2032-beta-fluoro-4\u2032-azidocytidine, against human and duck HBV replication","volume":"17","author":"Zheng","year":"2012","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.antiviral.2012.10.003_b0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2006.12.005","article-title":"Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo","volume":"74","author":"Zhou","year":"2007","journal-title":"Antiviral Research"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:23:00Z","timestamp":1542673380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0166354212002331"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.10.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}